O	O	O	0	12	Inactivation	Inactivation	B-NP	NN	O	20	NMOD	O
O	O	O	13	15	of	of	B-PP	IN	O	1	NMOD	O
T1	B-Protein	B-Protein	16	27	IkappaBbeta	IkappaBbeta	B-NP	NN	B-protein	2	PMOD	B-protein
O	O	O	28	30	by	by	B-PP	IN	O	1	NMOD	O
O	O	O	31	34	the	the	B-NP	DT	O	7	NMOD	O
T2	B-Protein	B-Protein	35	38	tax	tax	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	O	39	46	protein	protein	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	O	47	49	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	50	55	human	human	B-NP	JJ	O	15	NMOD	O
O	O	O	56	57	T	T	I-NP	NN	O	15	NMOD	O
O	O	O	57	58	-	-	I-NP	HYPH	O	15	NMOD	O
O	O	O	58	62	cell	cell	I-NP	NN	O	15	NMOD	O
O	O	O	63	71	leukemia	leukemia	I-NP	NN	O	15	NMOD	O
O	O	O	72	77	virus	virus	I-NP	NN	O	15	NMOD	O
O	O	O	78	82	type	type	I-NP	NN	O	8	PMOD	O
O	O	O	83	84	1	1	I-NP	CD	O	15	NMOD	O
O	O	O	84	85	:	:	O	:	O	1	P	O
O	O	O	86	87	a	a	B-NP	DT	O	20	NMOD	O
O	O	O	88	97	potential	potential	I-NP	JJ	O	20	NMOD	O
O	O	O	98	107	mechanism	mechanism	I-NP	NN	O	0	ROOT	O
O	O	O	108	111	for	for	B-PP	IN	O	20	NMOD	O
O	O	O	112	124	constitutive	constitutive	B-NP	JJ	O	23	NMOD	O
O	O	O	125	134	induction	induction	I-NP	NN	O	21	PMOD	O
O	O	O	135	137	of	of	B-PP	IN	O	23	NMOD	O
T24	B-Entity	B-Entity	138	140	NF	NF	B-NP	NN	B-protein	27	NMOD	B-protein
T24	I-Entity	I-Entity	140	141	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
T24	I-Entity	I-Entity	141	147	kappaB	kappaB	I-NP	NN	I-protein	24	PMOD	I-protein
O	O	O	147	148	.	.	O	.	O	20	P	O

O	O	O	150	152	In	In	B-PP	IN	O	12	VMOD	O
O	O	O	153	160	resting	rest	B-NP	VBG	B-cell_type	4	NMOD	B-cell_type
O	O	O	161	162	T	T	I-NP	NN	I-cell_type	4	NMOD	I-cell_type
O	O	O	163	174	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	1	PMOD	I-cell_type
O	O	O	174	175	,	,	O	,	O	12	P	O
O	O	O	176	179	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	180	193	transcription	transcription	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	194	200	factor	factor	I-NP	NN	I-protein	11	NMOD	I-protein
T25	B-Entity	B-Entity	201	203	NF	NF	I-NP	NN	B-protein	11	NMOD	B-protein
T25	I-Entity	I-Entity	203	204	-	-	B-NP	HYPH	I-protein	11	NMOD	I-protein
T25	I-Entity	I-Entity	204	210	kappaB	kappaB	I-NP	NN	I-protein	12	SUB	I-protein
O	O	O	211	213	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	214	225	sequestered	sequester	I-VP	VBN	O	12	VC	O
O	O	O	226	228	in	in	B-PP	IN	O	13	VMOD	O
O	O	O	229	232	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	233	242	cytoplasm	cytoplasm	I-NP	NN	O	14	PMOD	O
O	O	O	243	246	via	via	B-PP	IN	O	13	VMOD	O
O	O	O	247	259	interactions	interaction	B-NP	NNS	O	17	PMOD	O
O	O	O	260	264	with	with	B-PP	IN	O	18	NMOD	O
O	O	O	265	272	members	member	B-NP	NNS	O	19	PMOD	O
O	O	O	273	275	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	276	279	the	the	B-NP	DT	O	26	NMOD	O
O	O	O	280	281	I	I	I-NP	NN	B-protein	26	NMOD	B-protein
O	O	O	282	287	kappa	kappa	I-NP	NN	I-protein	26	NMOD	I-protein
O	O	O	288	289	B	B	I-NP	NN	I-protein	26	NMOD	I-protein
O	O	O	290	296	family	family	I-NP	NN	I-protein	21	PMOD	I-protein
O	O	O	297	299	of	of	B-PP	IN	O	26	NMOD	O
O	O	O	300	310	inhibitors	inhibitor	B-NP	NNS	O	27	PMOD	O
O	O	O	310	311	,	,	O	,	O	28	P	O
O	O	O	312	321	including	include	B-PP	VBG	O	28	NMOD	O
T3	B-Protein	B-Protein	322	334	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	33	NMOD	B-protein
O	O	O	335	338	and	and	I-NP	CC	O	33	NMOD	O
T4	B-Protein	B-Protein	339	350	IkappaBbeta	IkappaBbeta	I-NP	NN	B-protein	30	PMOD	B-protein
O	O	O	350	351	.	.	O	.	O	12	P	O

O	O	O	352	358	During	During	B-PP	IN	O	9	VMOD	O
O	O	O	359	365	normal	normal	B-NP	JJ	O	6	NMOD	O
O	O	O	366	367	T	T	I-NP	NN	O	6	NMOD	O
O	O	O	367	368	-	-	B-NP	HYPH	O	6	NMOD	O
O	O	O	368	372	cell	cell	I-NP	NN	O	6	NMOD	O
O	O	O	373	383	activation	activation	I-NP	NN	O	1	PMOD	O
O	O	O	383	384	,	,	O	,	O	9	P	O
T5	B-Protein	B-Protein	385	397	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	9	SUB	B-protein
O	O	O	398	400	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	401	408	rapidly	rapidly	I-VP	RB	O	9	VMOD	O
O	O	O	409	423	phosphorylated	phosphorylate	I-VP	VBN	O	9	VC	O
O	O	O	423	424	,	,	O	,	O	11	P	O
O	O	O	425	438	ubiquitinated	ubiquitinate	B-VP	VBN	O	11	VMOD	O
O	O	O	438	439	,	,	O	,	O	11	P	O
O	O	O	440	443	and	and	O	CC	O	11	VMOD	O
O	O	O	444	452	degraded	degrade	B-VP	VBN	O	11	VMOD	O
O	O	O	453	455	by	by	B-PP	IN	O	11	VMOD	O
O	O	O	456	459	the	the	B-NP	DT	O	20	NMOD	O
T26	B-Entity	B-Entity	460	463	26S	26S	I-NP	NN	B-protein	20	NMOD	B-protein
T26	I-Entity	I-Entity	464	474	proteasome	proteasome	I-NP	NN	I-protein	17	PMOD	I-protein
O	O	O	474	475	,	,	O	,	O	9	P	O
O	O	O	476	480	thus	thus	B-ADVP	RB	O	23	VMOD	O
O	O	O	481	491	permitting	permit	B-VP	VBG	O	9	VMOD	O
O	O	O	492	495	the	the	B-NP	DT	O	25	NMOD	O
O	O	O	496	503	release	release	I-NP	NN	O	23	OBJ	O
O	O	O	504	506	of	of	B-PP	IN	O	25	NMOD	O
O	O	O	507	517	functional	functional	B-NP	JJ	O	26	PMOD	O
T27	B-Entity	B-Entity	518	520	NF	NF	I-NP	NN	B-protein	30	NMOD	B-protein
T27	I-Entity	I-Entity	520	521	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
T27	I-Entity	I-Entity	521	527	kappaB	kappaB	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	O	527	528	.	.	O	.	O	9	P	O

O	O	O	529	531	In	In	B-PP	IN	O	18	VMOD	O
O	O	O	532	540	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	O	541	543	to	to	B-PP	TO	O	2	NMOD	O
O	O	O	544	547	its	its	B-NP	PRP$	O	6	NMOD	O
O	O	O	548	557	transient	transient	I-NP	JJ	O	6	NMOD	O
O	O	O	558	565	pattern	pattern	I-NP	NN	O	3	PMOD	O
O	O	O	566	568	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	569	576	nuclear	nuclear	B-NP	JJ	O	9	NMOD	O
O	O	O	577	586	induction	induction	I-NP	NN	O	7	PMOD	O
O	O	O	587	593	during	during	B-PP	IN	O	1	PMOD	O
O	O	O	594	596	an	an	B-NP	DT	O	13	NMOD	O
O	O	O	597	603	immune	immune	I-NP	JJ	O	13	NMOD	O
O	O	O	604	612	response	response	I-NP	NN	O	10	PMOD	O
O	O	O	612	613	,	,	O	,	O	18	P	O
T28	B-Entity	B-Entity	614	616	NF	NF	B-NP	NN	B-protein	17	NMOD	B-protein
T28	I-Entity	I-Entity	616	617	-	-	B-NP	HYPH	I-protein	17	NMOD	I-protein
T28	I-Entity	I-Entity	617	623	kappaB	kappaB	I-NP	NN	I-protein	18	SUB	I-protein
O	O	O	624	626	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	627	641	constitutively	constitutively	I-VP	RB	O	18	VMOD	O
O	O	O	642	651	activated	activate	I-VP	VBN	O	18	VC	O
O	O	O	652	654	in	in	B-PP	IN	O	20	VMOD	O
O	O	O	655	660	cells	cell	B-NP	NNS	O	21	PMOD	O
O	O	O	661	671	expressing	express	B-VP	VBG	O	22	NMOD	O
O	O	O	672	675	the	the	B-NP	DT	O	27	NMOD	O
T6	B-Protein	B-Protein	676	679	Tax	Tax	I-NP	NN	B-protein	27	NMOD	B-protein
O	O	O	680	692	transforming	transforming	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	O	693	700	protein	protein	I-NP	NN	I-protein	23	OBJ	I-protein
O	O	O	701	703	of	of	B-PP	IN	O	27	NMOD	O
O	O	O	704	709	human	human	B-NP	JJ	O	28	PMOD	O
O	O	O	710	711	T	T	I-NP	NN	O	29	NMOD	O
O	O	O	711	712	-	-	I-NP	HYPH	O	30	NMOD	O
O	O	O	712	716	cell	cell	I-NP	NN	O	35	NMOD	O
O	O	O	717	725	leukemia	leukemia	I-NP	NN	O	35	NMOD	O
O	O	O	726	731	virus	virus	I-NP	NN	O	35	NMOD	O
O	O	O	732	736	type	type	I-NP	NN	O	31	PMOD	O
O	O	O	737	738	I	I	I-NP	CD	O	35	NMOD	O
O	O	O	739	740	(	(	O	(	O	41	DEP	O
O	O	O	740	744	HTLV	HTLV	B-NP	NN	O	41	DEP	O
O	O	O	744	745	-	-	B-NP	HYPH	O	38	P	O
O	O	O	745	746	1	1	I-NP	CD	O	38	NMOD	O
O	O	O	746	747	)	)	O	)	O	35	NMOD	O
O	O	O	747	748	.	.	O	.	O	18	P	O

O	O	O	749	755	Recent	Recent	B-NP	JJ	O	2	NMOD	O
O	O	O	756	763	studies	study	I-NP	NNS	O	3	SUB	O
O	O	O	764	772	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	O	773	777	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	778	782	HTLV	HTLV	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	782	783	-	-	B-NP	HYPH	O	8	NMOD	O
O	O	O	783	784	1	1	I-NP	CD	O	8	NMOD	O
T7	B-Protein	B-Protein	785	788	Tax	Tax	I-NP	NN	B-protein	9	SUB	B-protein
O	O	O	789	796	targets	target	B-VP	VBZ	O	4	SBAR	O
T8	B-Protein	B-Protein	797	809	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	9	OBJ	B-protein
O	O	O	810	812	to	to	B-PP	TO	O	9	VMOD	O
O	O	O	813	816	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	817	826	ubiquitin	ubiquitin	I-NP	NN	B-protein	16	NMOD	B-protein
O	O	O	826	827	-	-	B-NP	HYPH	O	16	NMOD	O
T29	B-Entity	B-Entity	827	837	proteasome	proteasome	I-NP	NN	B-protein	16	NMOD	B-protein
O	O	O	838	845	pathway	pathway	I-NP	NN	O	11	PMOD	O
O	O	O	845	846	.	.	O	.	O	3	P	O

O	O	O	847	854	However	However	B-ADVP	RB	O	4	VMOD	O
O	O	O	854	855	,	,	O	,	O	4	P	O
O	O	O	856	858	it	it	B-NP	PRP	O	4	SUB	O
O	O	O	859	866	remains	remain	B-VP	VBZ	O	0	ROOT	O
O	O	O	867	874	unclear	unclear	B-ADJP	JJ	O	4	PRD	O
O	O	O	875	878	how	how	B-ADVP	WRB	O	4	VMOD	O
O	O	O	879	883	this	this	B-NP	DT	O	9	NMOD	O
O	O	O	884	889	viral	viral	I-NP	JJ	B-protein	9	NMOD	B-protein
O	O	O	890	897	protein	protein	I-NP	NN	I-protein	10	SUB	I-protein
O	O	O	898	905	induces	induce	B-VP	VBZ	O	6	SBAR	O
O	O	O	906	907	a	a	B-NP	DT	O	19	NMOD	O
O	O	O	908	918	persistent	persistent	I-NP	JJ	O	15	AMOD	O
O	O	O	919	925	rather	rather	B-PP	RB	O	15	AMOD	O
O	O	O	926	930	than	than	I-PP	IN	O	13	DEP	O
O	O	O	931	940	transient	transient	B-NP	JJ	O	18	NMOD	O
T30	B-Entity	B-Entity	941	943	NF	NF	I-NP	NN	B-protein	18	NMOD	B-protein
T30	I-Entity	I-Entity	943	944	-	-	B-NP	HYPH	I-protein	18	NMOD	I-protein
T30	I-Entity	I-Entity	944	950	kappaB	kappaB	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	O	951	959	response	response	I-NP	NN	O	10	OBJ	O
O	O	O	959	960	.	.	O	.	O	4	P	O

O	O	O	961	963	In	In	B-PP	IN	O	6	VMOD	O
O	O	O	964	968	this	this	B-NP	DT	O	3	NMOD	O
O	O	O	969	975	report	report	I-NP	NN	O	1	PMOD	O
O	O	O	975	976	,	,	O	,	O	6	P	O
O	O	O	977	979	we	we	B-NP	PRP	O	6	SUB	O
O	O	O	980	987	provide	provide	B-VP	VBP	O	0	ROOT	O
O	O	O	988	996	evidence	evidence	B-NP	NN	O	6	OBJ	O
O	O	O	997	1001	that	that	B-SBAR	IN	O	7	NMOD	O
O	O	O	1002	1004	in	in	B-PP	IN	O	17	VMOD	O
O	O	O	1005	1013	addition	addition	B-NP	NN	O	9	PMOD	O
O	O	O	1014	1016	to	to	B-PP	TO	O	10	NMOD	O
O	O	O	1017	1023	acting	act	B-VP	VBG	O	11	PMOD	O
O	O	O	1024	1026	on	on	B-PP	IN	O	12	VMOD	O
T9	B-Protein	B-Protein	1027	1039	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	13	PMOD	B-protein
O	O	O	1039	1040	,	,	O	,	O	17	P	O
T10	B-Protein	B-Protein	1041	1044	Tax	Tax	B-NP	NN	B-protein	17	SUB	B-protein
O	O	O	1045	1055	stimulates	stimulate	B-VP	VBZ	O	8	SBAR	O
O	O	O	1056	1059	the	the	B-NP	DT	O	19	NMOD	O
O	O	O	1060	1068	turnover	turnover	I-NP	NN	O	17	OBJ	O
O	O	O	1069	1071	Of	Of	B-PP	IN	O	19	NMOD	O
T11	B-Protein	B-Protein	1072	1083	IkappaBbeta	IkappaBbeta	B-NP	NN	B-protein	20	PMOD	B-protein
O	O	O	1084	1087	via	via	B-PP	IN	O	17	VMOD	O
O	O	O	1088	1089	a	a	B-NP	DT	O	26	NMOD	O
O	O	O	1090	1097	related	related	I-NP	JJ	O	26	NMOD	O
O	O	O	1098	1107	targeting	targeting	I-NP	NN	O	26	NMOD	O
O	O	O	1108	1117	mechanism	mechanism	I-NP	NN	O	22	PMOD	O
O	O	O	1117	1118	.	.	O	.	O	6	P	O

O	O	O	1119	1123	Like	Like	B-PP	IN	O	14	VMOD	O
T12	B-Protein	B-Protein	1124	1136	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	1	PMOD	B-protein
O	O	O	1136	1137	,	,	O	,	O	14	P	O
T13	B-Protein	B-Protein	1138	1141	Tax	Tax	B-NP	NN	B-protein	14	SUB	B-protein
O	O	O	1141	1142	-	-	B-VP	HYPH	O	4	NMOD	O
O	O	O	1142	1150	mediated	mediate	B-NP	VBN	O	7	NMOD	O
O	O	O	1151	1160	breakdown	breakdown	I-NP	NN	O	5	PMOD	O
O	O	O	1161	1163	of	of	B-PP	IN	O	7	NMOD	O
T14	B-Protein	B-Protein	1164	1175	IkappaBbeta	IkappaBbeta	B-NP	NN	B-protein	8	PMOD	B-protein
O	O	O	1176	1178	in	in	B-PP	IN	O	7	NMOD	O
O	O	O	1179	1190	transfected	transfecte	B-NP	VBN	B-cell_line	13	NMOD	B-cell_line
O	O	O	1191	1192	T	T	I-NP	NN	I-cell_line	13	NMOD	I-cell_line
O	O	O	1193	1204	lymphocytes	lymphocyte	I-NP	NNS	I-cell_line	10	PMOD	I-cell_line
O	O	O	1205	1207	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1208	1215	blocked	block	I-VP	VBN	O	14	VC	O
O	O	O	1216	1222	either	either	O	CC	O	15	VMOD	O
O	O	O	1223	1225	by	by	B-PP	IN	O	16	PMOD	O
O	O	O	1226	1230	cell	cell	B-NP	NN	O	22	NMOD	O
O	O	O	1230	1231	-	-	I-NP	HYPH	O	22	P	O
O	O	O	1231	1240	permeable	permeable	I-NP	JJ	O	22	NMOD	O
T31	B-Entity	B-Entity	1241	1251	proteasome	proteasome	I-NP	NN	O	22	NMOD	O
O	O	O	1252	1262	inhibitors	inhibitor	I-NP	NNS	O	17	PMOD	O
O	O	O	1263	1265	or	or	B-PP	CC	O	16	PMOD	O
O	O	O	1266	1268	by	by	B-PP	IN	O	16	PMOD	O
O	O	O	1269	1277	mutation	mutation	B-NP	NN	O	24	PMOD	O
O	O	O	1278	1280	Of	Of	B-PP	IN	O	25	NMOD	O
T15	B-Protein	B-Protein	1281	1292	IkappaBbeta	IkappaBbeta	B-NP	NN	B-protein	26	PMOD	B-protein
O	O	O	1293	1295	at	at	B-PP	IN	O	25	NMOD	O
O	O	O	1296	1299	two	two	B-NP	CD	O	31	NMOD	O
T32	B-Entity	B-Entity	1300	1306	serine	serine	I-NP	NN	O	31	NMOD	O
T32	I-Entity	I-Entity	1307	1315	residues	residue	I-NP	NNS	O	28	PMOD	O
O	O	O	1316	1323	present	present	B-ADJP	JJ	O	31	NMOD	O
O	O	O	1324	1330	within	within	B-PP	IN	O	32	AMOD	O
O	O	O	1331	1334	its	its	B-NP	PRP$	O	38	NMOD	O
T33	B-Entity	B-Entity	1335	1336	N	N	I-NP	NN	B-protein	38	NMOD	B-protein
T33	I-Entity	I-Entity	1336	1337	-	-	I-NP	HYPH	I-protein	38	NMOD	I-protein
T33	I-Entity	I-Entity	1337	1345	terminal	terminal	I-NP	JJ	I-protein	38	NMOD	I-protein
T33	I-Entity	I-Entity	1346	1352	region	region	I-NP	NN	I-protein	33	PMOD	I-protein
O	O	O	1352	1353	.	.	O	.	O	14	P	O

O	O	O	1354	1361	Despite	Despite	B-PP	IN	O	21	VMOD	O
O	O	O	1362	1365	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	1366	1370	dual	dual	I-NP	JJ	O	4	NMOD	O
O	O	O	1371	1382	specificity	specificity	I-NP	NN	O	1	PMOD	O
O	O	O	1383	1385	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	1386	1390	HTLV	HTLV	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	O	1390	1391	-	-	B-NP	HYPH	O	9	P	O
O	O	O	1391	1392	1	1	I-NP	CD	O	9	NMOD	O
T16	B-Protein	B-Protein	1393	1396	Tax	Tax	I-NP	NN	B-protein	5	PMOD	B-protein
O	O	O	1397	1400	for	for	B-PP	IN	O	4	NMOD	O
T17	B-Protein	B-Protein	1401	1413	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	1414	1417	and	and	I-NP	CC	O	13	NMOD	O
T18	B-Protein	B-Protein	1418	1429	IkappaBbeta	IkappaBbeta	I-NP	NN	B-protein	10	PMOD	B-protein
O	O	O	1430	1432	at	at	B-PP	IN	O	4	NMOD	O
O	O	O	1433	1436	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	1437	1444	protein	protein	I-NP	NN	O	17	NMOD	O
O	O	O	1445	1450	level	level	I-NP	NN	O	14	PMOD	O
O	O	O	1450	1451	,	,	O	,	O	21	P	O
T19	B-Protein	B-Protein	1452	1455	Tax	Tax	B-NP	NN	B-protein	21	SUB	B-protein
O	O	O	1456	1467	selectively	selectively	B-ADVP	RB	O	21	VMOD	O
O	O	O	1468	1478	stimulates	stimulate	B-VP	VBZ	O	0	ROOT	O
T34	B-Entity	B-Entity	1479	1481	NF	NF	B-NP	NN	B-protein	24	NMOD	B-protein
T34	I-Entity	I-Entity	1481	1482	-	-	I-NP	HYPH	I-protein	24	NMOD	I-protein
T34	I-Entity	I-Entity	1482	1488	kappaB	kappaB	I-NP	NN	I-protein	21	OBJ	I-protein
O	O	O	1488	1489	-	-	O	HYPH	O	24	NMOD	O
O	O	O	1489	1497	directed	direct	B-NP	VBN	O	27	NMOD	O
O	O	O	1498	1511	transcription	transcription	I-NP	NN	O	25	OBJ	O
O	O	O	1512	1514	of	of	B-PP	IN	O	27	NMOD	O
O	O	O	1515	1518	the	the	B-NP	DT	O	31	NMOD	O
T20	B-Protein	B-Protein	1519	1531	IkappaBalpha	IkappaBalpha	I-NP	NN	B-DNA	31	NMOD	B-DNA
O	O	O	1532	1536	gene	gene	I-NP	NN	I-DNA	28	PMOD	I-DNA
O	O	O	1536	1537	.	.	O	.	O	21	P	O

O	O	O	1538	1550	Consequently	Consequently	B-ADVP	RB	O	6	VMOD	O
O	O	O	1550	1551	,	,	O	,	O	6	P	O
T21	B-Protein	B-Protein	1552	1563	IkappaBbeta	IkappaBbeta	B-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	1564	1571	protein	protein	I-NP	NN	O	5	NMOD	O
O	O	O	1572	1582	expression	expression	I-NP	NN	O	6	SUB	O
O	O	O	1583	1585	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1586	1597	chronically	chronically	I-VP	RB	O	6	VMOD	O
O	O	O	1598	1611	downregulated	downregulate	I-VP	VBN	O	6	VC	O
O	O	O	1612	1614	in	in	B-PP	IN	O	8	VMOD	O
O	O	O	1615	1619	HTLV	HTLV	B-NP	NN	B-cell_type	16	NMOD	B-cell_type
O	O	O	1619	1620	-	-	B-NP	HYPH	I-cell_type	16	P	I-cell_type
O	O	O	1620	1621	1	1	I-NP	CD	I-cell_type	16	NMOD	I-cell_type
O	O	O	1621	1622	-	-	I-NP	HYPH	I-cell_type	16	NMOD	I-cell_type
O	O	O	1622	1630	infected	infect	I-NP	VBN	I-cell_type	16	NMOD	I-cell_type
O	O	O	1631	1632	T	T	I-NP	NN	I-cell_type	16	NMOD	I-cell_type
O	O	O	1633	1644	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	9	PMOD	I-cell_type
O	O	O	1644	1645	.	.	O	.	O	6	P	O

O	O	O	1646	1651	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1652	1660	findings	finding	I-NP	NNS	O	5	SUB	O
O	O	O	1661	1665	with	with	B-PP	IN	O	2	NMOD	O
T22	B-Protein	B-Protein	1666	1677	IkappaBbeta	IkappaBbeta	B-NP	NN	B-protein	3	PMOD	B-protein
O	O	O	1678	1685	provide	provide	B-VP	VBP	O	0	ROOT	O
O	O	O	1686	1687	a	a	B-NP	DT	O	8	NMOD	O
O	O	O	1688	1697	potential	potential	I-NP	JJ	O	8	NMOD	O
O	O	O	1698	1707	mechanism	mechanism	I-NP	NN	O	5	OBJ	O
O	O	O	1708	1711	for	for	B-PP	IN	O	8	NMOD	O
O	O	O	1712	1715	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	1716	1728	constitutive	constitutive	I-NP	JJ	O	12	NMOD	O
O	O	O	1729	1739	activation	activation	I-NP	NN	O	9	PMOD	O
O	O	O	1740	1742	of	of	B-PP	IN	O	12	NMOD	O
T35	B-Entity	B-Entity	1743	1745	NF	NF	B-NP	NN	B-protein	16	NMOD	B-protein
T35	I-Entity	I-Entity	1745	1746	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T35	I-Entity	I-Entity	1746	1752	kappaB	kappaB	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	O	1753	1755	in	in	B-PP	IN	O	12	NMOD	O
T23	B-Protein	B-Protein	1756	1759	Tax	Tax	B-NP	NN	B-protein	21	NMOD	B-protein
O	O	O	1759	1760	-	-	O	HYPH	O	18	P	O
O	O	O	1760	1770	expressing	express	B-VP	VBG	B-cell_type	21	NMOD	B-cell_type
O	O	O	1771	1776	cells	cell	B-NP	NNS	I-cell_type	17	PMOD	I-cell_type
O	O	O	1776	1777	.	.	O	.	O	5	P	O
